ICU Medical, Inc. (ICUI) vs Pulse Biosciences, Inc (PLSE)
ICU Medical, Inc. and Pulse Biosciences, Inc are both Medical Instruments & Supplies companies. ICU Medical, Inc. is the larger, with a market value of $4.2B against $3.8B — 1.1× the size. Pulse Biosciences, Inc has negative trailing earnings, so its P/E is not meaningful; ICU Medical, Inc. trades at 137×. ICU Medical, Inc. grew revenue faster over the last twelve months: −8.97% against −23.3%. ICU Medical, Inc. has the higher net margin (1.39% vs −6,755.8%) and the higher return on invested capital (1.46% vs 0.00%). Across the 18 metrics below, ICU Medical, Inc. leads on 14 and Pulse Biosciences, Inc on 4.
Valuation
Profitability
| Metric | ICUI | PLSE | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 39.13% | 0.25% | 54.62% |
| Operating margin | 3.34% | (7,007.76%) | 1.64% |
| Net margin | 1.39% | (6,755.78%) | 0.00% |
| Free cash flow margin | 7.08% | (5,180.42%) | 1.61% |
| Return on equity | 1.41% | (78.49%) | 0.00% |
| Return on assets | 0.74% | (67.90%) | 0.00% |
| Return on invested capital | 1.46% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack